SciELO - Scientific Electronic Library Online

vol.63 issue1A case of depersonalization with treatment-resistant depression successfully treated with sertraline-lamotrigine combination author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand



  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


West Indian Medical Journal

Print version ISSN 0043-3144

West Indian med. j. vol.63 no.1 Mona Jan. 2014




Leiomyoma of the prostate, a rare mesenchymal tumour



A ŞalvarciI; S AltinayII

IKonya Hospital, Department of Urology, Konya, Turkey
IIBağcilar Training and Research Hospital, Department of Pathology, Istanbul, Turkey




Keywords: Constipation, prostatic leiomyoma, urinary retention



The Editor,

Leiomyoma is a benign tumour composed of smooth muscles. It is observed in the prostate in two forms. Its first form is nodular leiomyomatosis frequently observed with benign prostate hypertrophy, whereas the second form is true prostatic leiomyoma which is very rarely observed (1). We present a case of a 62-year old man who presented to hospital with acute urinary retention and a past history of constipation (five years) and gross haematuria. Aurethral catheter was inserted.

Abenign, grade III tissue filling the rectum was observed on rectal examination. The international prostate symptom score (IPSS) was calculated as 33; Qmax 7, Qaver 3 and postmicturition residue urine was measured as 168 cc on the uroflowmeter. No pathological findings were observed in the bladder and kidneys on abdominal ultrasonography. Prostate specific antigen (PSA) 3.21 ng/mL and free PSA 1.1 ng/mL were measured. Uncomplicated open prostatectomy was performed.

A prostatic tissue weighing 103 grams in total was observed in the macroscopic assessment. It had a smooth surface and was encapsulated, forming a whole homogeneous mass. Clusters composed of spindle form and narrow cytoplasm cells crossing each other were observed in the histopathological evaluation. Atypical mitosis, pleomorphism or necrosis were not observed. Vimentin (+), desmin (+) and smooth muscle actin (SMA,+) displayed staining in the immunohistochemical staining while (-) staining was observed with CD 34 and S100 protein (Figs. 14). The patient was diagnosed with pure leiomyoma.









Leiomyoma of the prostate was first reported in 1876 by Lebec and true prostatic leiomyoma was specifically defined by Kaufman and Berneike (2). In this definition, it was expressed that it is a circumscribed or encapsulated mass of smooth muscle, 1 cm or more in diameter, containing varying amounts of fibrous tissue but devoid of glandular elements and which is either obviously prostatic or juxtaprostatic in origin and position (2, 3). Leiomyoma may be localized in many organs such as kidneys, ureter, bladder, urachus, prostate, urethra and seminal vesicles (4). The physiopathological mechanism of true prostatic leiomyoma has not been clarified (3–5). It has been suggested that repeated infections and inflammation can transform the glandular tissue into smooth muscle and the hypertrophy leads to leiomyoma (5, 6). Obstructive urinary complaints which cannot be distinguished from benign prostatic enlargement are frequently observed (7). More rarely, it may lead to constipation by placing pressure on the rectum (5). Leiomyoma led to long standing constipation in our patient. Gross haematuria is rarely observed.

When causing serious complaints, prostatic leiomyoma may be removed surgically. No recurrence and malignancy was observed (1, 7, 8).

Pure leiomyma of the prostate is a rarely observed tumour detected in this patient via histopathological examination. Diagnostic physical examination, laboratory analyses and specific radiological screening were not available prior to this pathological diagnosis.



We would like to thank Professor Mevlana Derya Balbay MD from Şişli Memorial Hospital, Department of Urology for his suggestions. Authors declare that there is no actual or potential conflict of interest in relation to this article.



1. Rubio Munoz A, Berné Manero JM, Bono Arino A, Sanz Velez JI, Esclarín Duny M, Marigil Gómez MA. Pure prostatic leiomyoma. Actas Urol Esp 2000; 24: 40–2. In Spanish

2. Kaufman JJ, Berneike RR. Leiyomyoma of the prostate. J Urol 1951; 65: 297–310.

3. Leonard A, Baert L, Van Praet F, Van de VoordeW, Van Poppel H, Lauweryns J. Solitary leiomyoma of the prostate. Br J Urol 1988; 62: 184–5.

4. Regan JB, Barrett DM, Wold LE. Giant leiomyoma of the prostate. Arch Pathol Lab Med 1987; 111: 381–2.

5. Barba J, Tolosa E, Panizo AF, Berián JM. Prostatic leiomyoma. Case report. Arch Esp Urol 2011; 64: 631–5.

6. Vassilakis GB. Pure leiomyoma of prostate. Urology 1978; 11: 93–4.

7. Mellas S, Bouchikhi AA, Tazi MF, Khallouk A, Elammari JE, El Fassi MJ et al. Prostatic leiomyoma: a case report. Case Rep Urol 2012; 2012: 702762. doi: 10.1155/2012/702762. Epub 2012 Nov 11.

8. Yilmaz F, Sahin H, Hakverdi S, Arslan A, Bircan MK, Kiliç N. Huge leiomyoma of the prostate. Scandinavian J Urol Nephrol 1998; 32: 223–4.



Dr A Şalvarci,
Konya Hospital,
Şemsi Tebrizi Mh Şerafettin Caddesi No: 95,
Karatay, Konya, Turkey 42200.